Home

Mark E Saad

CIK 1295913 · Chief Financial Officer · last filed 2026-06-10

Mark E Saad is a Chief Financial Officer who has filed 47 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for AXSM, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$8.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.27M

Companies

3

Total Filings

47

Lifetime Open-Market Net

-$7.99M

Filer Profile

Reported Address
C/O AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 29TH FLOOR
NEW YORK, NY 92121
Phone
(858) 458-0900
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AXSM Director 11,731 $193.45 $2.27M -$8.16M 27 2026-06-10
Catheter Precision, Inc. (RMED) Delisted Director 275 $0.59 $163 $0 5 2021-01-07
PLUS THERAPEUTICS, INC. (CYTX) Delisted Chief Financial Officer 9,229 — — $171.8K 12 2013-02-04

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-10 AXSM Exer (M) +1,429 $0 EDGAR
2026-06-09 AXSM Grant (A) — $0 EDGAR
2026-01-02 AXSM Mixed — -$6.00M EDGAR
2025-12-31 AXSM Notice (144) −37,577 -$6.21M EDGAR
2025-09-05 AXSM Notice (144) −9,127 -$1.14M EDGAR
2025-09-05 AXSM Mixed — -$1.06M EDGAR
2025-06-10 AXSM Grant (A) — $0 EDGAR
2025-02-25 AXSM Grant (A) — $0 EDGAR
2024-09-11 AXSM Notice (144) −11,016 -$1.01M EDGAR
2024-09-11 AXSM Mixed — -$965.4K EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.